Park Place Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.6K Hold
482
0.01% 360
2025
Q4
$51.2K Sell
482
-14
-3% -$1.62K 0.01% 323
2025
Q3
$63K Sell
496
-100
-17% -$11.9K 0.01% 295
2025
Q2
$71.8K Buy
+596
New +$68.1K 0.02% 297
2024
Q2
Sell
-19
Closed -$1.57K 874
2024
Q1
$1.57K Hold
19
﹤0.01% 853
2023
Q4
$1.27K Hold
19
﹤0.01% 821
2023
Q3
$1.28K Hold
19
﹤0.01% 964
2023
Q2
$1.29K Sell
19
-250
-93% -$15.7K ﹤0.01% 978
2023
Q1
$14.6K Sell
269
-32
-11% -$1.86K ﹤0.01% 703
2022
Q4
$18K Buy
+301
New +$16.4K 0.01% 672

Other funds holding EHC

Park Place Capital's EHC Position: Q1 2026 in Review

Park Place Capital held its Encompass Health (EHC) position steady in Q1 2026 at 482 shares worth $46.6K. The position accounts for 0.01% of the portfolio, ranked #360.

Park Place Capital first reported a position in EHC in Q4 2022 and has held it in 10 quarters since. The position peaked at $71.8K in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Park Place Capital held 482 shares of Encompass Health worth $46.6K as of Q1 2026.
  • Park Place Capital left its Encompass Health share count unchanged in Q1 2026.
  • Encompass Health made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #360 holding.
  • Park Place Capital first reported a position in Encompass Health in Q4 2022 and has held it in 10 quarters since.
  • Park Place Capital's Encompass Health position peaked at $71.8K in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.